Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.

Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...

Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.

The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.

Get The Healthy by Reader’s Digest newsletter Diabetes mellitus is a disorder where ... via injection under the skin or via an insulin pump. “Diabetes technology—insulin pumps and continuous ...

Insulin pumps are a medical device used by people with diabetes to automatically deliver a measured dose of insulin into their bloodstream. Traditionally they have involved a canula and separate ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults ...

A person with type 2 diabetes has developed insulin resistance. When this occurs, the body does not respond properly to insulin, which the pancreas produces. This insufficient response causes a ...

People with type 1 diabetes need insulin therapy, either through injections or an insulin pump, for the rest of ... Neonatal diabetes mellitus (NDM) develops in babies between six months and ...

Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high morbidity and mortality worldwide. In affected people, insulin is unable to ...

OBJECTIVE Children and adults with type 1 diabetes who receive insulin pump therapy have reported hypoglycemia during air travel. We studied the effects of atmospheric pressure on insulin pump ...